HealthCare Global Enterprises Limited (NSE:HCG)
India · Delayed Price · Currency is INR 659.90
+3.90 (0.59%)
May 27, 2026, 3:29 PM IST
NSE:HCG Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, NSE:HCG stock has a consensus rating of "Strong Buy" and an average price target of ₹779.56. The average 1-year stock price forecast is 18.13% higher than the current stock price, while the lowest is ₹724.00 (+9.71%) and the highest is ₹920.00 (+39.42%).
Price Target: ₹779.56 (+18.13%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 27, 2026.
Analyst Ratings
The average analyst rating for NSE:HCG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 7 | 8 | 8 |
| Buy | 2 | 3 | 3 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst ICICI Securities No rating | ICICI Securities | Buy Maintains ₹710.00 | Buy | Maintains | ₹710.00 | +7.59% | Feb 27, 2026 |
| Geojit Research | Geojit Research | Buy Upgrades ₹724.00 | Buy | Upgrades | ₹724.00 | +9.71% | Feb 19, 2026 |
Unknown Analyst Axis Direct No rating | Axis Direct | Buy Maintains ₹750.00 | Buy | Maintains | ₹750.00 | +13.65% | Feb 10, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.